Response to "Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0.015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp'

被引：0

作者：

Malvehy, J. ^{[1
,2
,3
,4
]}

Puig, S. ^{[1
,2
,3
,4
]}

机构：

[1] Hosp Clin Barcelona, Melanoma Unit, Dermatol Dept, Barcelona, Spain

[2] Univ Barcelona, Barcelona, Spain

[3] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain

[4] Inst Salud Carlos III, CIBER Enfermedades Raras, Barcelona, Spain

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2018年 / 178卷 / 03期

关键词：

D O I：

10.1111/bjd.16216

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Linked article: Br J Dermatol 2018;

引用

收藏

页码：812 / 813

页数：2

相关论文

共 3 条

[1] Ingenol Mebutate Gel for Actinic Keratosis
Lebwohl, Mark
Swanson, Neil
Anderson, Lawrence L.
Melgaard, Anita
Xu, Zhenyi
Berman, Brian
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (11) : 1010 - 1019
[2] Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group
Pflugfelder, A.
Welter, A. -K.
Leiter, U.
Weide, B.
Held, L.
Eigentler, T. K.
Dirschka, T.
Stockfleth, E.
Nashan, D.
Garbe, C.
[J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (01) : 48 - 53
[3] Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0•015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp
Stockfleth, E.
Harwood, C. A.
Serra-Guillen, C.
Larsson, T.
Osterdal, M. L.
Skov, T.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (02) : 433 - 442